211 related articles for article (PubMed ID: 11113983)
1. A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease.
Grace JB; Walker MP; McKeith IG
Int J Geriatr Psychiatry; 2000 Nov; 15(11):1028-33. PubMed ID: 11113983
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase inhibitors for dementia with Lewy bodies.
Wild R; Pettit T; Burns A
Cochrane Database Syst Rev; 2003; 2003(3):CD003672. PubMed ID: 12917981
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.
Rozzini L; Chilovi BV; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
Am J Alzheimers Dis Other Demen; 2007; 22(1):42-7. PubMed ID: 17534001
[TBL] [Abstract][Full Text] [Related]
4. Higher Frequency and Complexity of Sleep Disturbances in Dementia with Lewy Bodies as Compared to Alzheimer's Disease.
Chwiszczuk L; Breitve M; Hynninen M; Gjerstad MD; Aarsland D; Rongve A
Neurodegener Dis; 2016; 16(3-4):152-60. PubMed ID: 26551998
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
Kaufer DI
Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():32-9. PubMed ID: 14676467
[TBL] [Abstract][Full Text] [Related]
6. Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.
Maclean LE; Collins CC; Byrne EJ
Int Psychogeriatr; 2001 Sep; 13(3):277-88. PubMed ID: 11768375
[TBL] [Abstract][Full Text] [Related]
7. Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.
McKeith IG; Grace JB; Walker Z; Byrne EJ; Wilkinson D; Stevens T; Perry EK
Int J Geriatr Psychiatry; 2000 May; 15(5):387-92. PubMed ID: 10822236
[TBL] [Abstract][Full Text] [Related]
8. Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
Grace J; Daniel S; Stevens T; Shankar KK; Walker Z; Byrne EJ; Butler S; Wilkinson D; Woolford J; Waite J; McKeith IG
Int Psychogeriatr; 2001 Jun; 13(2):199-205. PubMed ID: 11495394
[TBL] [Abstract][Full Text] [Related]
9. Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease.
Finkel SI
Clin Ther; 2004 Jul; 26(7):980-90. PubMed ID: 15336465
[TBL] [Abstract][Full Text] [Related]
10. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
[TBL] [Abstract][Full Text] [Related]
11. Sleep-Wake Profile in Dementia with Lewy Bodies, Alzheimer's Disease, and Normal Aging.
Cagnin A; Fragiacomo F; Camporese G; Turco M; Bussè C; Ermani M; Montagnese S
J Alzheimers Dis; 2017; 55(4):1529-1536. PubMed ID: 27886007
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of monitoring sleep talking for the diagnosis of Dementia with Lewy bodies.
Honda K; Hashimoto M; Yatabe Y; Kaneda K; Yuki S; Ogawa Y; Matsuzaki S; Tsuyuguchi A; Tanaka H; Kashiwagi H; Hasegawa N; Ishikawa T; Ikeda M
Int Psychogeriatr; 2013 May; 25(5):851-8. PubMed ID: 23425512
[TBL] [Abstract][Full Text] [Related]
13. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
Touchon J; Bergman H; Bullock R; Rapatz G; Nagel J; Lane R
Curr Med Res Opin; 2006 Jan; 22(1):49-59. PubMed ID: 16393430
[TBL] [Abstract][Full Text] [Related]
14. Dementia with lewy bodies: findings from an international multicentre study.
Del Ser T; McKeith I; Anand R; Cicin-Sain A; Ferrara R; Spiegel R
Int J Geriatr Psychiatry; 2000 Nov; 15(11):1034-45. PubMed ID: 11113984
[TBL] [Abstract][Full Text] [Related]
15. Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer's disease using the Multiple Sleep Latency Test.
Ferman TJ; Smith GE; Dickson DW; Graff-Radford NR; Lin SC; Wszolek Z; Van Gerpen JA; Uitti R; Knopman DS; Petersen RC; Parisi JE; Silber MH; Boeve BF
Alzheimers Res Ther; 2014; 6(9):76. PubMed ID: 25512763
[TBL] [Abstract][Full Text] [Related]
16. [The possible value of diagnosing MCI-DLB and treatment options].
Feitsma MT; van Laar T; Dautzenberg PL
Tijdschr Gerontol Geriatr; 2009 Sep; 40(4):168-72. PubMed ID: 20088343
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.
McKeith I; Del Ser T; Spano P; Emre M; Wesnes K; Anand R; Cicin-Sain A; Ferrara R; Spiegel R
Lancet; 2000 Dec; 356(9247):2031-6. PubMed ID: 11145488
[TBL] [Abstract][Full Text] [Related]
18. The high frequency of periodic limb movements in patients with Lewy body dementia.
Hibi S; Yamaguchi Y; Umeda-Kameyama Y; Yamamoto H; Iijima K; Momose T; Akishita M; Ouchi Y
J Psychiatr Res; 2012 Dec; 46(12):1590-4. PubMed ID: 22835911
[TBL] [Abstract][Full Text] [Related]
19. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Mol JA
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712655
[No Abstract] [Full Text] [Related]
20. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Moerkens RM; Dhondt AD
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712654
[No Abstract] [Full Text] [Related]
[Next] [New Search]